Market Analysis
The global avian influenza vaccine market is likely
to touch USD 1.18 Billion at a 7.5% CAGR during the forecast period, according
to the recent report by Market Research Future (MRFR). Avian influenza, or what
is popularly called bird flu, is a form of viral infection that transfers from
one bird to another. This can infect humans and other animals as well. Goose,
duck, turkey, and chicken are some of its common applications.
Various factors are adding to the global avian influenza vaccine market growth. Such factors, according
to the new MRFR report, include rising strategic agreements, growing private
and public initiatives undertaken via the government & non-government
organizations for R&D, and a growing number of outbreaks. Additional
factors adding market growth include ongoing research to develop effective
vaccines to prevent the disease and increasing demand for poultry for
consumption.
On the contrary, the inefficient performance and
rapid deterioration at room temperature in just a few hours are factors that
may restrict the global avian influenza vaccine market growth over the forecast
period.
Market Segmentation
The MRFR report offers an inclusive segmental
analysis of the global avian influenza vaccine market report by application
& strain.
Based on strain, the avian influenza vaccine market
has been segmented into H5, H7, & H9. Among these, the H5 segment will lead
the market over the forecast period as it is the most commonly used.
Based on application, the avian influenza vaccine
market has been segmented into goose, turkey, chicken, and duck. Of these, the
chicken segment will dominate the market over the forecast period over the
forecast period.
Regional Analysis
Based on the region, the avian influenza vaccine
market report covers the recent trends and growth opportunities across the
Americas, Europe, the Asia Pacific (APAC), and the Middle East and Africa
(MEA). Of these, both the Middle East and APAC will spearhead the market over
the forecast period. Factors boosting the avian influenza vaccine market growth
in the region include numerous initiatives by the government for effective and
rapid avian influenza management in the region coupled with an increase in
avian influenza outbreaks. Besides, the increasing research and development
expenditure by several key players in the region is also adding market
growth.
In Europe, the avian influenza vaccine market is
predicted to hold the second-largest share over the forecast period for private
entities and collaborative initiatives by the government for promoting improved
animal health coupled with rising production of veterinary products. The EU is closely working together with
the World Organization for Animal Health, the Food and Agriculture
Organization, and the World Health Organization in response to the worldwide
threat of avian flu.
Key Players
The global avian influenza vaccine market players are Avimex Animal Health
(Mexico), QYH BIOTECH COMPANY LIMITED (China), Guangdong Wenshi Dahuanong
Biotechnology Co., Ltd (China), JOVAC (Jordan), PT Japfa Comfeed Indonesia Tbk
(Indonesia), Medion (Indonesia), Merck Animal Health (US), Chengdu Tech-bank
Biological Products Co., Ltd (China), FATRO S.P.A. (Italy), Yebio
Bioengineering Co., Ltd (China),Tianjin Ringpu Bio-Technology Co., Ltd (China),
CAVAC (South Korea), Zoetis (US), Ceva (US), and Boehringer Ingelheim
International GmbH (Germany).
About
Market Research Future:
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting
Services. MRFR team have supreme objective to provide the optimum quality
market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research
and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
Comments
Post a Comment